Revolution Medicines (RVMD) earnings per share (EPS)

Earnings per share · fiscal 2025
-$5.95

Revolution Medicines (RVMD) reported diluted earnings per share of -$5.95 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$3.58. Figures as of 17 Nov 2026, 22:17 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Earnings per share, fiscal 2025
-$5.95
Highest on record
-$2.01fiscal 2020
Lowest on record
-$5.95fiscal 2025
Fiscal years on record
62020–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Revolution Medicines earnings per share (EPS), in more detail

Across the 6 fiscal years on record (2020–2025), the highest was -$2.01 in fiscal 2020 and the lowest -$5.95 in fiscal 2025.

History · 6 fiscal years

Earnings per share by fiscal year

Revolution Medicines earnings per share (EPS), year by year

Revolution Medicines (RVMD) earnings per share (EPS) by fiscal year
Fiscal yearEarnings per shareChangeYear ended
2025-$5.95—
2024-$3.58—
2023-$3.86—
2022-$3.08—
2021-$2.57—
2020-$2.01—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

How to read it

It shows how much profit stands behind each share, so it rises when profit grows or when buybacks shrink the share count.

Earnings per share at health care companies of similar size

Earnings per share of Revolution Medicines and comparable companies
CompanyEarnings per shareFiscal year
BeOne Medicines ONC$2.472025
Waters WAT$10.762025
Natera NTRA-$1.522025
IQVIA Holdings IQV$7.842025
Revolution Medicines RVMD-$5.952025
Royalty Pharma RPRX$1.782025

The latest fiscal year on record for each company, in the currency it reports in. Fiscal years end at different times of year.

More on RVMD

Revolution Medicines, figure by figure

Revolution Medicines (RVMD) overview: price, valuation and scorecardAll health care companies by market value

Revolution Medicines earnings per share (EPS): questions and answers

What is Revolution Medicines's diluted earnings per share?

Revolution Medicines (RVMD) reported diluted earnings per share of -$5.95 in fiscal 2025 (the year ended December 31, 2025). In fiscal 2024 the figure was -$3.58.

What are the highest and lowest diluted earnings per share figures on record for Revolution Medicines?

Across the 6 fiscal years on record (2020–2025), the highest was -$2.01 in fiscal 2020 and the lowest -$5.95 in fiscal 2025.

How is Revolution Medicines's diluted earnings per share calculated?

Earnings per share is net income divided by the diluted number of shares, as the company reports it; older years are re-based for later stock splits.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Revolution Medicines (RVMD) earnings per share (EPS)”, data as of 17 November 2026. https://funkfolio.com/stock/RVMD/eps

Underlying data: the company's filings with the SEC and Yahoo Finance.